Schistosomiasis vaccine development: progress and prospects-Reference-Cited by-同舟云学术

Schistosomiasis vaccine development: progress and prospects

Published:1998 Issue:suppl 1 Volume:93 Page:95-101
ISSN:0074-0276
Container-title:Memórias do Instituto Oswaldo Cruz
language:
Short-container-title:Mem. Inst. Oswaldo Cruz

Author:

Bergquist NR¹

Affiliation:

1. WHO, Switzerland

Publisher

FapUNIFESP (SciELO)

Subject

Microbiology (medical)

Link

http://www.scielo.br/pdf/mioc/v93s1/13.pdf

Reference30 articles.

1. A purified 28 000 Dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis;Balloul JM;J Immunol,1987

2. Vaccination of Patas monkeys experimentally infected with Schistosoma haema-tobium using recombinant glutathione S-transferase cloned from Schistosoma mansoni;Boulanger D;Parasite Immunol,1995

3. Human immunity to Schistosoma mansoni: observations on mechanisms and implications for control;Butterworth AE;Immunol Invest,1992

4. Development of a vaccine strategy against human and bovine schistosomiasis: Background and update;Capron A;Mem Inst Oswaldo Cruz,1995

5. Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes;Coulson PS;Infect Immun,1997

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HGPRT and PNP: Recombinant Enzymes from Schistosoma mansoni and Their Role in Immunotherapy during Experimental Murine Schistosomiasis;Pathogens;2023-03-29

2. China’s Experiences in the Combat of Schistosomiasis;Public Health in China;2022

3. Immunogenicity, antibody responses and vaccine efficacy of recombinant annexin B30 against Schistosoma mansoni;Parasite Immunology;2020-01-21

4. Molecular characterization of Schistosoma mansoni tegument annexins and comparative analysis of antibody responses following parasite infection;Molecular and Biochemical Parasitology;2019-12

5. The use of gold nanorods as a new vaccine platform against schistosomiasis;Journal of Controlled Release;2018-04